Erik Billings
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
HIV Research and Treatment, Immunotherapy and Immune Responses, Virology and Viral Diseases, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial(2012)1,823 cited
- → Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys(2012)464 cited
- → Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys(2013)339 cited
- → The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120(2012)211 cited
- → Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition(2016)203 cited
- → Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial(2013)191 cited
- → Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIV mac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial(2012)133 cited
- → Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection(2017)59 cited
- → Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition(2016)36 cited
- → Molecular epidemiology of a primarily MSM acute HIV‐1 cohort in Bangkok, Thailand and connections within networks of transmission in Asia(2018)21 cited